Skrabal Katharina, Saragosti Sentob, Labernardière Jean-Louis, Barin Francis, Clavel François, Mammano Fabrizio
INSERM U552 Recherche Antivirale, Paris, France.
J Virol. 2005 Sep;79(18):11848-57. doi: 10.1128/JVI.79.18.11848-11857.2005.
Individuals infected with human immunodeficiency virus type 1 (HIV-1) harbor a mixture of viral variants with different sequences and in some instances with different phenotypic properties. Major and rapid fluctuations in the proportion of viral variants coexisting in an infected individual can be observed under strong pharmacological and immune selective pressure. Because of the short half-life of HIV-infected cells and of HIV virions in the blood, plasma virus populations are highly relevant to HIV evolution in the face of these selective pressures. Here we analyzed the sensitivity to antibody-mediated neutralization of viral variants coexisting in the plasma virus populations of two infected patients. For each patient, several replication-competent viral clones were constructed that carry primary envelope gene sequences obtained from a single plasma sample. Viral clones differed in their tropism and replicative capacity and in the number and positions of glycosylation sites in the envelope glycoproteins. Viruses were tested against heterologous and autologous sera obtained at different time points. Interestingly, we found that viral variants coexisting in each plasma sample were highly heterogeneous in terms of sensitivity to neutralization. The order of sensitivity depended on the serum used and was not associated with virus tropism. The neutralization potency of sera increased with the duration of the infection for both autologous and heterologous neutralization.
感染1型人类免疫缺陷病毒(HIV-1)的个体体内携带着多种具有不同序列的病毒变体,在某些情况下还具有不同的表型特性。在强大的药理和免疫选择压力下,可以观察到感染个体体内共存的病毒变体比例出现重大且快速的波动。由于HIV感染细胞和血液中HIV病毒粒子的半衰期较短,面对这些选择压力时,血浆病毒群体与HIV进化高度相关。在此,我们分析了两名感染患者血浆病毒群体中共存的病毒变体对抗体介导中和作用的敏感性。对于每位患者,构建了几个具有复制能力的病毒克隆,这些克隆携带从单个血浆样本中获得的主要包膜基因序列。病毒克隆在嗜性、复制能力以及包膜糖蛋白中糖基化位点的数量和位置方面存在差异。使用在不同时间点获得的异源和同源血清对病毒进行检测。有趣的是,我们发现每个血浆样本中共存的病毒变体在对中和作用的敏感性方面高度异质。敏感性顺序取决于所使用的血清,且与病毒嗜性无关。对于同源和异源中和作用,血清的中和效力均随感染持续时间的增加而增强。